Nutraceuticals in the Prevention and Treatment of Neurodegenerative Diseases, Health Within Reach

Authors

  • Katia López Torres Instituto de Investigaciones Químico-Biológicas, Universidad Michoacana de San Nicolás de Hidalgo. Morelia, Michoacán México.
  • Josué Altamirano Hernández Instituto de Investigaciones Químico-Biológicas, Universidad Michoacana de San Nicolás de Hidalgo. Morelia, Michoacán México.
  • Asdrúbal Aguilera Méndez Instituto de Investigaciones Químico-Biológicas, Universidad Michoacana de San Nicolás de Hidalgo. Morelia, Michoacán México.

Keywords:

Neurodegenerative diseases, nutraceuticals, prevention

Abstract

Neurodegenerative diseases are a group of brain disorders with highly diverse clinical manifestations that share a common feature: cognitive deterioration due to neuronal death. These diseases have a higher incidence in older adults, posing a significant public health problem in Mexico and worldwide. Currently, there is no cure for these diseases, and available medications are very costly and have side effects. For this reason, non-pharmacological treatments have been proposed, with nutraceuticals standing out among them. Nutraceuticals aim to prevent diseases and enhance the body’s physiological activities. They have been categorized, according to their composition, into probiotics, vitamins/minerals, and antioxidants. Various studies have confirmed a reduction in symptoms during neurodegeneration, as well as lower costs and side effects, presenting great potential for success.

Downloads

Download data is not yet available.

References

Ahmad, S. S., Khalid, M., Kamal, M. A., & Younis, K. (2021). Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review. Current neuropharmacology, 19(11), 1884–1895. https://doi.org/10.2174/1570159x19666210215122333

Arora, K., Green, M., & Prakash, S. (2020). The microbiome and Alzheimer’s disease: potential and limitations of prebiotic, synbiotic, and probiotic formulations. Frontiers in bioengineering and biotechnology, 8, 53784. https://doi.org/10.3389/fbioe.2020.537847

Birnbaum, G., & Stulc, J. (2017). High dose biotin as treatment for progressive multiple sclerosis. Multiple Sclerosis and Related Disorders, 18, 141-143. https://doi.org/10.1016/j.msard.2017.09.030

Carapia-Vega, N., Fonseca-Valtierra, R. E., de León, K. V. N. D., Saavedra-Triana, G. M., & Escobedo-Martínez, C. (2024). Alimentos funcionales y nutracéuticos. El papel que juegan en la salud. JÓVENES EN LA CIENCIA, 28. http://dx.doi.org/10.15174/jc.2024.4490

Hernández Espinosa, D. R., Barrera Morín, V., Briz Tena, O., González Herrera, E. A., Laguna Maldonado, K. D., Jardínez Díaz, A. S., & Matuz Mares, D. (2019). El papel de las especies reactivas de oxígeno y de nitrógeno en algunas enfermedades neurodegenerativas. Revista de la Facultad de Medicina (México), 62(3), 6-19. https://doi.org/10.22201/fm.24484865e.2019.62.3.03

Latorre, M. A. D. (2023). Rol de suplementación con probióticos en el desarrollo y la evolución de la Enfermedad de Alzheimer y Enfermedad de Parkinson. Revista de Nutrición Clínica y Metabolismo. http://dx.doi.org/10.35454/rncm.v6n3.504

OMS, (2019). Dementias. https://www.paho.org/es/temas/demencia#:~:text=América%20Latina%20y%20el%20Caribe%20serán%20los%20más%20afecados%2C%20con,las%20Américas%2C%20representando%20390.473%20defunciones.

Talaverón-Rey, M., Álvarez-Córdoba, M., Villalón-García, I., Povea-Cabello, S., Suárez Rivero, J. M., Gómez-Fernández, D., Romero-González, A., Suárez-Carrillo, A., Munuera-Cabeza, M., Cilleros-Holgado, P., Reche-López, D., Piñero-Pérez, R., & Sánchez Alcázar, J. A. (2023). Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase associated neurodegeneration with residual PANK2 expression levels. Orphanet Journal of Rare Diseases, 18(1). https://doi.org/10.1186/s13023-023-02687-5

Sienes Bailo, P., Llorente Martín, E., Calmarza, P., Montolio Breva, S., Bravo Gómez, A., Pozo Giráldez, A., ... & Fort Gallifa, I. (2022). Implicación del estrés oxidativo en las enfermedades neurodegenerativas y posibles terapias antioxidantes. Advances in Laboratory Medicine/Avances en Medicina de Laboratorio, 3(4), 351-360. https://doi.org/10.1515/almed-2022-0022

Published

2025-11-27

How to Cite

López Torres, K., Altamirano Hernández, J., & Aguilera Méndez, A. (2025). Nutraceuticals in the Prevention and Treatment of Neurodegenerative Diseases, Health Within Reach. Milenaria, Ciencia Y Arte, (26), 38–41. Retrieved from http://www.milenaria.umich.mx/ojs/index.php/milenaria/article/view/507

Issue

Section

Artículos